Zenas-logo-rgb.png
Zenas BioPharma Mengumumkan Pelantikan Kepimpinan Eksekutif Baharu
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. Presiden yang dilantik, CEO dan Pemangku CMO Joe Farmer, CBO yang dilantik HONG KONG dan BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), sebuah syarikat...
Zenas-logo-rgb.png
Zenas BioPharma Anuncia Novas Nomeações de Liderança Executiva
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. nomeado Presidente, CEO e CMO em exercício Joe Farmer nomeado CBO HONG KONG e BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- A Zenas BioPharma (“Zenas”), uma empresa biofarmacêutica...
Zenas-logo-rgb.png
Zenas BioPharma anuncia nuevos nombramientos de liderazgo ejecutivo
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. nombrado presidente, director ejecutivo y director médico interino Joe Farmer nombrado director de negocios HONG KONG y BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma...
Zenas-logo-rgb.png
Zenas BioPharma ประกาศแต่งตั้งผู้บริหารระดับสูงคนใหม่
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. แต่งตั้งให้ดำรงตำแหน่งประธาน, CEO และรักษาการ CMO Joe Farmer แต่งตั้งให้ดำรงตำแหน่ง CBO ฮ่องกงและบอสตัน, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (ต่อไปนี้จะเรียกว่า...
MacroGenics-Logo-(transparent-background).png
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
April 29, 2021 16:01 ET | MacroGenics, Inc.
MARGENZA™ launched in mid-March Upcoming poster presentation of MGC018 initial Phase 1 clinical data at ASCOConference call scheduled for today at 4:30 p.m. ET. ROCKVILLE, Md., April 29, 2021 ...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call
April 19, 2021 16:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, April 19, 2021 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
HEALTHTECH SOLUTIONS, INC. ANNOUNCES CONTRACT TO ACQUIRE VARIAN BIOPHARMACEUTICALS, A PRECISION ONCOLOGY COMPANY
March 31, 2021 15:11 ET | Healthtech Solutions, Inc.
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“HLTT” or the “Company”)  today announces that it has entered into an agreement to acquire a...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Zenas-logo-rgb.png
Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies
March 23, 2021 04:00 ET | Zenas BioPharma (USA) LLC
Lead product candidate, ZB001, has first-in-class potential in China for Thyroid Eye Disease Rapidly advancing seven pipeline programs, including three worldwide, with best-in-class potential in...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET | Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...